EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

The Prognostic Potential of PD-L1, PD-1, CD3, CD4, and CD8 Expression in Patients with Head and Neck Cancers Depending on HPV16 Infection

Anna Mucha-Małecka, Beata Biesaga, Natalia Amrogowicz, Aleksandra Grela-Wojewoda, Mirosława Püsküllüoğlu iD, Marcin Przewoźnik, Elżbieta Pluta, Anna Patla, Krzysztof Roszkowski iD, Krzysztof Małecki

Cancers · 28.05.2026 · 18 (11) · 1771

DOI: 10.3390/cancers18111771 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cancers, online erschienen am 28.05.2026. Verfasst von Anna Mucha-Małecka und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Garncarska Street 11, 31-115 Cracow, Polan…. Die Arbeit nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Count Jakub Potocki Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

The aim of this study was to evaluate the expression of PD-L1, PD-1, CD3, CD4, and CD8 in tumor tissues of patients with head and neck squamous cell carcinoma from southern Poland, and to assess their prognostic value in relation to disease-free survival (DFS), taking into account HPV16 status and other clinical, pathological, and demographic factors. Material/Methods: This study included 155 unselected patients with head and neck squamous cell carcinoma (HNSCC) from the southern Poland region, who underwent diagnostic evaluation and surgical treatment. Formalin-fixed, paraffin-embedded (FFPE) tissue blocks were obtained from these centers. The patients were treated at the Maria Skłodowska-Curie National Research Institute of Oncology, Kraków Branch, between 1991 and 2014, with treatment approaches including induction therapy (preoperative), adjuvant therapy (postoperative), or definitive chemoradiotherapy with cisplatin. Protein expression was assessed using immunohistochemistry and quantified (TPS, CPS, H-score). Relationships between expression levels and epidemiological, clinical, and histopathological features were analyzed.

Results

The results show that PD-L1 overexpression was associated with worse DFS, whereas overexpression of PD-1, CD3, CD4, and CD8 correlated with improved DFS. These associations were statistically significant in the HPV16-negative subgroup, while no such correlations were found in HPV16-positive patients. In multivariate analysis, independent prognostic factors associated with improved DFS included HPV16 infection, absence of PD-L1 overexpression, overexpression of CD4 and CD8, and combined chemoradiotherapy with cisplatin.

Conclusions

These findings confirm the prognostic relevance of PD-L1, PD-1, and T-cell markers in HNSCC, particularly in HPV16-negative patients, and support further research into the use of these biomarkers in personalized treatment strategies.

Schlagwörter

Stichwörter der Autor:innen

HPV16head and neck cancersimmune checkpointsprognostic biomarkers

Autor:innen und Institutionen

  • Department of Radiotherapy, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Garncarska Street 11, 31-115 Cracow, Poland.
  • Department of Tumor Pathology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Garncarska Street 11, 31-115 Cracow, Poland.
  • First Radiation and Clinical Oncology Department, Maria Sklodowska-Curie National Research Institute of Oncology, 44-102 Gliwice, Poland.
  • Department of Clinical Oncology, Maria Sklodowska-Curie National Research Institute of Oncology, Krakow Branch, Garncarska Street 11, 31-115 Cracow, Poland.
  • Department of Oncology, Collegium Medicum, Nicolaus Copernicus University, 85-821 Bydgoszcz, Poland.
  • Department of Radiotherapy for Children and Adults, University Children's Hospital of Cracow, Wielicka 265, 30-663 Cracow, Poland.

ORCID-Profile: Mirosława Püsküllüoğlu, Krzysztof Roszkowski

Förderung

  • Count Jakub Potocki Foundation

Zitieren

APA

Mucha-Małecka, A., Biesaga, B., Amrogowicz, N., Grela-Wojewoda, A., Püsküllüoğlu, M., Przewoźnik, M., Pluta, E., Patla, A., Roszkowski, K., & Małecki, K. (2026). The Prognostic Potential of PD-L1, PD-1, CD3, CD4, and CD8 Expression in Patients with Head and Neck Cancers Depending on HPV16 Infection. Cancers, 18(11), 1771. https://doi.org/10.3390/cancers18111771

Vancouver

Mucha-Małecka A, Biesaga B, Amrogowicz N, Grela-Wojewoda A, Püsküllüoğlu M, Przewoźnik M, et al. The Prognostic Potential of PD-L1, PD-1, CD3, CD4, and CD8 Expression in Patients with Head and Neck Cancers Depending on HPV16 Infection. Cancers. 2026;18(11):1771. doi:10.3390/cancers18111771

BibTeX
@article{MuchaMaecka2026,
  author = {Mucha-Małecka, Anna and Biesaga, Beata and Amrogowicz, Natalia and Grela-Wojewoda, Aleksandra and Püsküllüoğlu, Mirosława and Przewoźnik, Marcin and Pluta, Elżbieta and Patla, Anna and Roszkowski, Krzysztof and Małecki, Krzysztof},
  title = {The Prognostic Potential of PD-L1, PD-1, CD3, CD4, and CD8 Expression in Patients with Head and Neck Cancers Depending on HPV16 Infection},
  journal = {Cancers},
  year = {2026},
  volume = {18},
  number = {11},
  pages = {1771},
  doi = {10.3390/cancers18111771}
}
Kostenlos starten →